Tianjin Cancer Institute and Hospital
Tianjin Cancer Institute and Hospital
Tianjin, Tianjin Municipality, China1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase II Trial of Perioperative Adebrelimab Combined With XELOX in Resectable Locally Advanced Gastric/Gastroesophageal Junction Cancer (GC/GEJC) | Adebrelimab (SHR-1316); GC/GEJC; XELOX | Recruiting | Phase 2 | 2024-07-17 | NCT06506292 |